Their specific loss leads to larger tumors that exhibit reduced infiltration of both CD4+ and CD8+ T-cells, despite the fact that T-cell priming appears to be normal in tumor-bearing BATF3-/- mice. This evidence concerns the gene CD8A and neoplasm.